Preferred Label : Abbott Architect SARS-CoV-2 IgM Serology Assay;
NCIt definition : A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection
of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT
i system. The presence of IgM antibodies may be associated with recent infection or
may assist with the evaluation of disease course.;
NCI Metathesaurus CUI : CL1663321;
Origin ID : C180707;
UMLS CUI : C5556572;
Semantic type(s)
- concept_is_in_subset
